Search results
28 gru 2012 · A generic version of Eliquis has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Eliquis and have been approved by the FDA:
15 sie 2024 · Today, the U.S. Department of Health and Human Services released the “Maximum Fair Price” (MFP) for a 30-day supply of ELIQUIS® (apixaban), which was selected in the first round of government price setting as part of the Inflation Reduction Act (IRA).
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with...
10 gru 2021 · Between 2014 and 2019, the average spending per claim decreased for low‐molecular‐weight heparins ($554–$226), increased for apixaban ($243–$374), dabigatran ($267–$376), and rivaroxaban ($237–$400), and remained stable for warfarin ($12–$14).
29 maj 2020 · Because Apixaban Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s. Why is Apixaban Accord authorised in the EU?
By 2030, up to 80 drugs will have lower negotiated prices. One of the first ten drugs selected for negotiation is Eliquis, a drug used to treat blood clots, manufactured by Bristol Myers Squibb and Pfizer.
14 sty 2023 · One pharmacist says a generic version could cut the price from $600 a month to $12. Pharmaceutical companies fought to restore the patent and now a generic won't be available for several more...
